First-trimester maternal serum activin A in pre-eclampsia and fetal growth restriction
- 1 March 2004
- journal article
- research article
- Published by Taylor & Francis in The Journal of Maternal-Fetal & Neonatal Medicine
- Vol. 15 (3) , 176-180
Abstract
Objective: To investigate whether the reported increase in maternal serum activin A concentration in pre-eclampsia is evident from the first trimester.Design: This was a case-control study carried out in antenatal clinics among singleton pregnancies at 10–14 weeks of gestation.Methods: Activin A concentration was measured in stored maternal serum samples obtained at 11–14 weeks of gestation from 131 women who subsequently developed pre-eclampsia, 77 who developed non-proteinuric pregnancy-induced hypertension, 141 with fetal growth restriction in the absence of hypertensive complications and from 494 normotensive controls.Results: Compared to the median activin A level in the control group (1.00 MoM), the median MoM in the patients who subsequently developed pre-eclampsia and pregnancy-induced hypertension (1.49 MoM and 1.32 MoM, respectively) was significantly increased (p<0.001), and in patients with fetal growth restriction (1.02 MoM) it was not significantly different (p=0.57). In the pre-eclampsia group (n=131) the disease was considered to be sufficiently severe to necessitate iatrogenic delivery before 35 weeks in 25 patients, and in this group the median MoM was 1.92.Conclusion: Maternal serum activin A concentration at 12 weeks of gestation in pregnancies which subsequently develop hypertensive disease is increased, whereas in those complicated by fetal growth restriction it is normal.Keywords
This publication has 21 references indexed in Scilit:
- Maternal serum activin A levels in association with intrauterine fetal growth restrictionBJOG: An International Journal of Obstetrics & Gynaecology, 2003
- The addition of activin A and inhibin A measurement to uterine artery Doppler velocimetry to improve the early prediction of pre‐eclampsiaUltrasound in Obstetrics & Gynecology, 2003
- Screening for pre‐eclampsia and fetal growth restriction by uterine artery Doppler at 11–14 weeks of gestationUltrasound in Obstetrics & Gynecology, 2001
- Multicenter screening for pre‐eclampsia and fetal growth restriction by transvaginal uterine artery Doppler at 23 weeks of gestationUltrasound in Obstetrics & Gynecology, 2001
- A screening program for trisomy 21 at 10–14 weeks using fetal nuchal translucency, maternal serum free β‐human chorionic gonadotropin and pregnancy‐associated plasma protein‐AUltrasound in Obstetrics & Gynecology, 1999
- Hypoxia alters early gestation human cytotrophoblast differentiation/invasion in vitro and models the placental defects that occur in preeclampsia.Journal of Clinical Investigation, 1996
- Hypertension in pregnancy: Changes in activin a maternal serum concentrationPlacenta, 1995
- Placental bed spiral arteries in the hypertensive disorders of pregnancyBJOG: An International Journal of Obstetrics & Gynaecology, 1991
- The Transforming Growth Factor-beta FamilyAnnual Review of Cell Biology, 1990
- Inadequate maternal vascular response to placentation in pregnancies complicated by pre‐eclampsia and by small‐for‐gestational age infantsBJOG: An International Journal of Obstetrics & Gynaecology, 1986